SCHEMBL3802061

SCHEMBL3802061

Fc1ccccc1Cc1cncnc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 4/20 0.37
TAAR1 Q96RJ0 2/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
ADCY10 Q96PN6 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
NPC1 O15118 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
AR P10275 1/20 0.35
MPO P05164 1/20 0.35
IDO1 P14902 2/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9493067 0.83 CYP1A2 (0.43) ALDH1A1TAAR1HTR2CHTR2BMEN1
SCHEMBL858731 0.77 CYP11B1 (0.40) ALDH1A1TAAR1MEN1KMT2ACYP1A2
SCHEMBL5410799 0.73 AR (0.41) TDP1ALDH1A1TAAR1MEN1KMT2A
SCHEMBL30951651 0.73 HRH3 (0.45) TDP1ALDH1A1TAAR1L3MBTL1NPC1
SCHEMBL3301625 0.73 TAAR1 (0.59) ALDH1A1TAAR1L3MBTL1ARMPO
SCHEMBL856298 0.71 ALDH1A1 (0.40) ALDH1A1TAAR1ADCY10KMT2AL3MBTL1
SCHEMBL17436168 0.70 HDAC6 (0.43) TDP1ALDH1A1TAAR1HTR2CHTR2B
SCHEMBL1442670 0.70 ADRB2 (0.45) TDP1ALDH1A1KMT2AL3MBTL1NPC1
SCHEMBL11195639 0.70 TAAR1 (0.50) ALDH1A1TAAR1MEN1KMT2AL3MBTL1
SCHEMBL1442705 0.69 L3MBTL1 (0.56) TDP1ALDH1A1ADCY10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010135568-A1 BENZOXAZEPINES AS INHIBITORS OF MTOR AND THEIR USE TO TREAT CANCER EXELIXIS, INC. (US) 2010-11-25 WO disclosed